SESN2 prevents the slow-to-fast myofiber shift in denervated atrophy via AMPK/PGC - 1α pathway

Background: Sestrin2 (SESN2), a stress-inducible protein, has been reported to protect against denervated muscle atrophy through unfolded protein response and mitophagy, while its role in myofiber type transition remains unknown. Methods: A mouse sciatic nerve transection model was created to evaluate denervated muscle atrophy. Myofiber type transition was confirmed by western blot, fluorescence staining, ATP quantification, and metabolic enzyme activity analysis. Adenoassociated virus (AAV) was adopted to achieve SESN2 knockdown and overexpression in gastrocnemius. AMPK/PGC-1 alpha signal was detected by western blot and activated with 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR). C2C12 myotubes with rotenone treatment were adopted for in vitro experiments. Results: SESN2 was found to be upregulated in denervated skeletal muscles and rotenone-treated C2C12 cells. Knockdown of SESN2 aggravated muscle atrophy and accelerated myofiber type transition from slow-twitch to fast-twitch. Moreover, AMPK/PGC-1 alpha signaling was proven to be activated by SESN2 after denervation, which further induced the expression of hypoxia-inducible factor HIF2 alpha. Exogenous activation of AMPIVPGC-1 alpha signaling could counteract the addition of slow-to-fast myofiber shift caused by SESN2 knockdown and lead to the retainment of muscle mass after denervation. Conclusion: Collectively, the present study indicates that SESN2 prevents myofiber type transition from slow-twitch to fast-twitch and preserves muscle mass in denervated atrophy via AMPK/PGC-1 alpha signaling. These findings contribute to a better understanding of the pathogenesis of muscle atrophy and provide novel insights into the role of SESN2 in myofiber type transition.

Automated summary

Through experiments, it was found that SESN2 can prevent the transition from slow-twitch to fast-twitch myofibers, and preserve muscle mass in denervated atrophy. Additionally, SESN2 can activate AMPK/PGC-1 alpha signaling, which further induces the expression of hypoxia-inducible factor HIF2 alpha.